S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q1 2025

RA Capital Management

Period: Q1 2025 Β· Filed: 2025-05-15
View on SEC EDGAR β†—
AUM
$5.99B
Total portfolio value
Positions
85
Reported securities
Top Holding
ASND
26.8% $1.60B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$1.60B26.76%$155.86$274.50+76.1%
26.8%
PCVXVAXCYTE INC$460.3M7.69%$37.76$58.39+54.6%
7.7%
RYTMRHYTHM PHARMACEUTICALS INC$322.3M5.38%$52.97$114.17+115.5%
5.4%
JANXJANUX THERAPEUTICS INC$302.1M5.05%$27.00$15.54-42.4%
5.0%
NAMSNEWAMSTERDAM PHARMA CO NV$207.5M3.47%$20.47$34.83+70.2%
3.5%
ACLXARCELLX INC$199.2M3.33%$65.60β€”
3.3%
EWTXEDGEWISE THERAPEUTICS INC$196.0M3.27%$22.00$39.56+79.8%
3.3%
RNAMAVIDITY BIOSCIENCES INC$186.0M3.11%β€”β€”
3.1%
WVEWAVE LIFE SCIENCES LTD$147.1M2.46%$8.08$6.26-22.5%
2.5%
ETNB89BIO INC$144.6M2.41%β€”β€”
2.4%
SPRYARS PHARMACEUTICALS INC$136.6M2.28%$12.58$8.56-32.0%
2.3%
SIONSIONNA THERAPEUTICS INC$109.3M1.82%$10.46$43.99+320.6%
1.8%
LENZLENZ THERAPEUTICS INC$107.4M1.79%$25.71$5.89-77.1%
1.8%
DYNDYNE THERAPEUTICS INC$101.6M1.70%$10.46$23.07+120.5%
1.7%
TYRATYRA BIOSCIENCES INC$98.9M1.65%$9.30$30.62+229.3%
1.6%
MLYSMINERALYS THERAPEUTICS INC$97.6M1.63%$15.88$27.69+74.4%
1.6%
GERNGERON CORP$96.0M1.60%$1.59$1.36-14.5%
1.6%
RXSTRXSIGHT INC$94.5M1.58%$25.25$5.61-77.8%
1.6%
BCAXBICARA THERAPEUTICS INC$90.6M1.51%$13.03$29.00+122.6%
1.5%
IRONDISC MEDICINE INC$78.3M1.31%$49.64$76.26+53.6%
1.3%
GHRSGH RESEARCH PLC$76.6M1.28%$11.03$27.01+144.9%
1.3%
APGEAPOGEE THERAPEUTICS INC$58.6M0.98%$37.36$132.91+255.8%
1.0%
DNTHDIANTHUS THERAPEUTICS INC$52.0M0.87%$18.14$94.34+420.1%
0.9%
ZLABZAI LAB LTD-ADR$46.8M0.78%$36.14$19.12-47.1%
0.8%
DAWNDAY ONE BIOPHARMACEUTICALS I$45.6M0.76%β€”β€”
0.8%
SEPNSEPTERNA INC$40.5M0.68%$5.79$34.00+487.2%
0.7%
TRMLTOURMALINE BIO INC$38.6M0.64%β€”β€”
0.6%
CLYMCLIMB BIO INC$38.3M0.64%$1.22$12.90+957.4%
0.6%
SRRKSCHOLAR ROCK HOLDING CORP$36.5M0.61%$32.15$54.88+70.7%
0.6%
URGNUROGEN PHARMA LTD$35.5M0.59%$11.06$38.02+243.8%
0.6%

Quarter-on-Quarter Activity

Q1 2025 vs. Q4 2024

New Positions (8)

TickerIssuerNotionalSince Filing
SIONSIONNA THERAPEUTICS INC$109.3M+320.6%
IRONDISC MEDICINE INC$78.3M+53.6%
URGNUROGEN PHARMA LTD$35.5M+243.8%
GKOSGLAUKOS CORP$18.7M
MTSRMETSERA INC$18.4M
RCUSARCUS BIOSCIENCES INC$8.9M
ACHCACADIA HEALTHCARE CO INC$6.6M
BBNXBETA BIONICS INC$6.1M

Exited Positions (8)

TickerIssuerNotional
LEGNLEGEND BIOTECH CORP-ADR$244.3M
XBISPDR S&P BIOTECH ETF$110.6M
AXSMAXSOME THERAPEUTICS INC$84.6M
VRNAVERONA PHARMA PLC - ADR$82.0M
PRAXPRAXIS PRECISION MEDICINES I$58.6M
RXRXRECURSION PHARMACEUTICALS-A$52.2M
EVHEVOLENT HEALTH INC - A$40.2M
CMRXCHIMERIX INC$30.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SRRKSCHOLAR ROCK HOLDING CORP$35.8M+6351.3%+70.7%
SRZNSURROZEN INC$3.9M+140.3%
GERNGERON CORP$-10.2M+101.2%-14.5%
ITOSITEOS THERAPEUTICS INC$5.7M+74.4%
DNTHDIANTHUS THERAPEUTICS INC$11.3M+53.6%+420.1%
DYNDYNE THERAPEUTICS INC$-48.7M+52.2%+120.5%
PCVXVAXCYTE INC$-251.0M+40.3%+54.6%
ETNB89BIO INC$33.8M+40.3%

Trimmed (4)

TickerIssuerNotionalShares Ξ”
DRUGBright Minds Biosciences Inc$-9.2M-55.2%
TXG10X GENOMICS INC-CLASS A$-30.1M-40.7%
BIOABIOAGE LABS INC$-3.6M-19.7%
KURAKURA ONCOLOGY INC$-12.3M-10.0%
← Back to Hedge Funds
RA Capital Management Q1 2025 13F Filing β€” Holdings & Portfolio | MarketsFN